# Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

> **Open Intelligence Dossier** · First detected: 2026-07-31 15:07 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include FirstWord Pharma, Yahoo Finance, reuters.com and WSJ. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Fierce Biotech | Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail | [Source Link](https://news.google.com/rss/articles/CBMixwFBVV95cUxNaFRuNE5zdE5Wa0ZfcHhvdkJmOWppREVvOTdUTjVBYXRJbndURGZyN09ZTjl5dkIwU2JPeVFldVd2SUIzZV9VYjV3eHZ5U21FZTNvUzloSHY5bXlXb24yY0NnRGUwdG9lSk5udXNRSV83TERSdVBwc0hrOTV4djJ4bVliVGVoOTRzejUzWG1XYlZ6dFRvRE5CNzNuRFo2dV9SRmU1Mk1HOWx4QTFMVERCeTNfalJtODhwZFJfT2ZCZDNzLUczdElJ?oc=5) |
| STAT | Novo Nordisk inflammation-targeting drug misses mark in heart disease study | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxQUnp1cllYOHNOeFUxa3A0VlprcmFjNVpib3E0bktXalVqOVk1NThpbmROa19vUGFuNlBQODE5dC1BT1ZIR0NWRWlhQ3Y2VUM5VmdoWVlYTGh6dzBIbnBwSG9wQkJWYnVxVXRraFVhcmtQZjQzUTU4ZFlKUHU4TzZmb1BNOUJ3WkNPZkt1V0lxem1PbTA?oc=5) |
| FirstWord Pharma | Novo hit by failure of key pipeline hopeful ziltivekimab in CV outcomes study | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE1mdkNtUzh3R0FDNVdmZXFnOG5VVWRqamhyMFAyWGkyV2hLdTh1SXhOMkg1M3Q4Z1lyQ2JTcWRhWXhKaHdUb2hJRmppa1VReldyOVFZ?oc=5) |
| Yahoo Finance | Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQOWN4MDJOMmJub1lXTjRHZXFLbHlOSE9wYXFSbHkxbE1LVThBTEZNell3ZXNSemN2bm0yMU5jTmNDdlNVMkVWSDdnUjBqYjZQLUVJX3pob2xKMXB1em5PMkdUMWlMM1R6VnBDbjNieGptV0ZYM01JRlZMMTJCOFBYNW9ScmlKZmhnY3p3Q2E3NDJmYWhEcDRZSA?oc=5) |
| reuters.com | Novo drug fails to reduce cardiovascular risk in late-stage trial, shares slide | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxPR0hId1RlLVEwR1pIdkEtOVA2QklyZ0l5TE1INUJKR3plRklPLXZFVXNBdkpWSGc1bm92QVF4NWJMR2QxUHlhUUlGdGk1NHN3Q3RpVHdSZ084YkhhRnlMRTVaZFBaWDF2dTJDZkZaOHZVNXdQaXc5bGZDc2d2bTVvNFBNUXEzQjJWcE9hRlRqamtuTE1leUxBdFBMaDhWUE5IR1cyR0hta0VsN2RMWVNlS291ZmRISElfMjNLSVVxdC0?oc=5) |
| WSJ | Novo Nordisk Shares Drop After Drug Candidate Fails in Trial | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxNYUVLc1lmLWpldzZTem13d0tucEU4bnZET1ZxWEpoeVNjcmowekdvX05rMUlDMXJPVW9BUW12YkxNODBuM1lzeDI5MlhtRHlrRldjNlhSRFFvaDFNWkh6NFVIY04tU25saXFGUkMxaGJmNEhVSE5qaV9QWldQem83V0wtTGtQTjZZQy1YMnVfR2hLWnNvenJfb09KSTk5WjRFNFJJdzczVklTUjdaZDIzdXZCTzRJOUtYOFE?oc=5) |
| CNBC | Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline | [Source Link](https://news.google.com/rss/articles/CBMicEFVX3lxTE1WWkV5OHhpMC00MEYyNDdlSFluM090ZW9zUWFSWU4zS21YTG1lX2xJZEtWaGpneW0ydnVpYVQyYWxTR05FNG5mSjlPS05lZm1jcmxTVnZxNzA0T0FfRUotNlFRU3QwUGhwLWZTdXBpVFjSAXZBVV95cUxQSlhTVzdqd19IMTFCUWhBUmk1aW9hLTdaNktUd2ZETDU4NkxaUzduNlJBNDJVeXo0YTN2VXFMekhrckFsZ0tnQTlzT2JTSkpPWHY1OWJtMUFVVTY0Yko3YnFjejFKVlBwV1pqOXVWdkozTXloall3?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-31/novo-nordisk-shares-dive-after-heart-medicine-fails-trial-dealing-another-blow*